* The Immune Response Corp., of Carlsbad, Calif., published resultsof its HIV vaccine Remune in combination with antiviral drugtherapy in the September issue of the Journal of ClinicalImmunology. Results from 92 HIV patients treated with Remuneindicated CD4 percentage and viral load stabilized in an observationperiod up to 48 weeks. A positive cell-mediated response increasedafter injection with Remune.
(c) 1997 American Health Consultants. All rights reserved.